NHS pilot found half of children had mutations in their tumours that would be targetable by drugs available for adults Those children who did receive targeted treatments saw significant benefits But only 7 per cent of children with ‘clinically actionable’ mutations could access appropriate drugs, partly due to regulatory and funding barriers, and lack of […]
Precision Medicine for Children with Cancer








